BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing commercial-stage specialty pharmaceutical company dedicated to patients living with chronic conditions, announced on November 25, 2019 that it has named Dr. Singh, to its Board of Directors. “We are very excited and honored to have Dr. Singh join our organization as a Board member,” stated Peter Greenleaf, Chairman of BDSI. Read full press release. Comments are closed.
|
Archives
May 2023
Categories |